Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
about
Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patientsGeneration of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy.HLA-E expression and its clinical relevance in human renal cell carcinoma.Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation.Tumor-infiltrating CD45RO+ memory cells correlate with favorable prognosis in patients with lung adenocarcinoma.
P2860
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@en
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@nl
type
label
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@en
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@nl
prefLabel
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@en
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.
@nl
P2860
P50
P1476
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
@en
P2093
Magnus Pedersen
P2860
P304
P356
10.1080/21645515.2015.1075106
P577
2015-01-01T00:00:00Z